Work

Supplementary Figure 1 from The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti–CTLA-4 Therapy

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 57K

DOI: 10.1158/0008-5472.22388831.v1

Authors: Tihui Fu, Qiuming He, Padmanee Sharma

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361894462

Cites:

Cited by:

Related to: 10